{
    "title": "Eli Lilly's weak diabetes drugs sales cloud 2023 profit forecast",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11705587/Eli-Lilly-forecasts-annual-profit-estimates.html",
    "date": "2023-02-02",
    "keywords": [
        "drug",
        "quarter",
        "mounjaro",
        "year",
        "treatment",
        "bhanvi",
        "satija",
        "wingrove",
        "street",
        "blockbuster",
        "profit",
        "cancer",
        "revenue",
        "david",
        "company",
        "approval",
        "loss",
        "reporting",
        "feb",
        "type",
        "condition",
        "forecast",
        "drugmaker",
        "hit",
        "price",
        "insulin",
        "competition",
        "therapy",
        "alimta",
        "access",
        "svb",
        "analyst",
        "risinger",
        "increase",
        "offlabel",
        "obesity",
        "market",
        "trulicity",
        "verzenio",
        "spot",
        "investor",
        "chief",
        "executive",
        "investment",
        "growth",
        "time",
        "dont",
        "cap",
        "pharma",
        "core",
        "business",
        "number",
        "disease",
        "mid2023",
        "covid19",
        "antibody",
        "bebtelovimab",
        "health",
        "regulator",
        "authorization",
        "coronavirus",
        "decline",
        "share",
        "potential",
        "tax",
        "rate",
        "york",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "bill",
        "bekrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}